Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Tranquilyn 20mg tablets
0404000M0BFACAK
|
Tranquilyn | Methylphenidate hydrochloride | Central Nervous System | 98 |
|
Venlasov XL 75mg capsules
0403040W0CDAAAD
|
Venlasov | Venlafaxine | Central Nervous System | 98 |
|
Bio-Melatonin 3mg tablets
0401010ADBCBZCY
|
Melatonin (Proprietary preparations) | Melatonin | Central Nervous System | 97 |
|
Li-Liquid 1.018g/5ml oral solution
0402030P0BDABAK
|
Li-Liquid | Lithium citrate | Central Nervous System | 97 |
|
Strattera 4mg/1ml oral solution
0404000S0BBAHAK
|
Strattera | Atomoxetine hydrochloride | Central Nervous System | 97 |
|
Granisetron 1mg tablets
0406000M0AAABAB
|
Granisetron hydrochloride | Granisetron hydrochloride | Central Nervous System | 96 |
|
Levetiracetam 750mg gran for soln sachets sugar free
0408010A0AAASAS
|
Levetiracetam | Levetiracetam | Central Nervous System | 96 |
|
Teglutik 5mg/1ml oral suspension
0409030R0BCAAAD
|
Teglutik | Riluzole | Central Nervous System | 96 |
|
Clobazam 5mg/5ml oral liquid
040801060AAA1A1
|
Clobazam | Clobazam | Central Nervous System | 95 |
|
Nicorette QuickMist SmartTrack 1mg/dose mouthspray
0410020B0BBBGBW
|
Nicorette | Nicotine | Central Nervous System | 94 |
|
Sodium Amytal 60mg capsules
0401030E0BBAAAA
|
Sodium amytal | Amobarbital sodium | Central Nervous System | 94 |
|
Xeplion 150mg/1.5ml prolonged-release inj pf syringes
0402020ABBBADAD
|
Xeplion | Paliperidone | Central Nervous System | 94 |
|
Mirapexin 0.7mg tablets
0409010W0BBAAAA
|
Mirapexin | Pramipexole | Central Nervous System | 93 |
|
Venzip XL 75mg capsules
0403040W0CEAAAD
|
Venzip | Venlafaxine | Central Nervous System | 93 |
|
Diazepam 10mg/2ml solution for injection ampoules
0401020K0AAACAC
|
Diazepam | Diazepam | Central Nervous System | 92 |
|
Morphine 200mg modified-release capsules
0407020Q0AAEIEI
|
Morphine sulfate | Morphine sulfate | Central Nervous System | 92 |
|
Buprenorphine 40micrograms/hour transdermal patches
0407020B0AAANAN
|
Buprenorphine (Opioid Analgesic) | Buprenorphine | Central Nervous System | 91 |
|
Nicotine bitartrate 2mg lozenges sugar free
0410020D0AAAAAA
|
Nicotine bitartrate | Nicotine bitartrate | Central Nervous System | 90 |
|
Co-codamol 30mg/500mg/5ml oral solution sugar free
0407010F0AAAZAZ
|
Co-codamol | Co-codamol (Codeine phosphate/paracetamol) | Central Nervous System | 89 |
|
Prometax 4.6mg/24hours transdermal patches
0411000E0BHABAF
|
Prometax | Rivastigmine | Central Nervous System | 89 |
|
Valios 20mg orodispersible tablets sugar free
0411000G0BFABAG
|
Valios | Memantine hydrochloride | Central Nervous System | 89 |
|
Molipaxin 50mg capsules
0403010X0BBAAAA
|
Molipaxin | Trazodone hydrochloride | Central Nervous System | 88 |
|
Nabilone 1mg capsules
0406000R0AAAAAA
|
Nabilone | Nabilone | Central Nervous System | 88 |
|
Stilnoct 5mg tablets
0401010Y0BBAAAA
|
Stilnoct | Zolpidem tartrate | Central Nervous System | 88 |
|
Abstral 300microgram sublingual tablets
0407020A0BJACAY
|
Abstral | Fentanyl | Central Nervous System | 87 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.